摘要
目的:探讨COPD合并呼吸衰竭呼吸内科规范治疗效果。方法:收治COPD合并呼吸衰竭患者78例,将其按奇、偶数字法随机平均分为两组。对照组给予常规治疗;观察组在对照组基础上加用沙美特罗替卡松治疗。结果:观察组治疗后各项指标均优于对照组(P<0.05)。结论:沙美特罗替卡松治疗COPD合并呼吸衰竭患者能够有效缓解其呼吸困难症状,对促进肺功能恢复及提高患者生活质量均具有重要作用。
Objective:To investigate the standard treatment effect of COPD combined respiratory failure.Methods:78 patients with COPD combined respiratory failure were selected.They were randomly divided into two groups according to the odd and even numbers.The control group were given conventional treatment,while the observation group were treated with Shah Mette Lo Tikason on the basis of the control group.Results:The indexes of the observation group were better than those in the control group(P<0.05).Conclusion:Shah Mette Lo Tikason can effectively relieve the symptoms of dyspnea in patients with COPD combined with respiratory failure,and it plays an important role in promoting pulmonary function recovery and improving the quality of life of patients.
出处
《中国社区医师》
2015年第26期35-36,共2页
Chinese Community Doctors
关键词
慢性阻塞性肺疾病
呼吸衰竭
常规治疗
沙美特罗替卡松
肺功能
Chronic obstructive pulmonary disease
Respiratory failure
Conventional therapy
Shah Mette Lo Tikason
Pulmonary function
